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Abstract
The project explores the opportunity to invest in Kompuestos, a Spain-based listed company, dedicated to produce 
and commercialize Masterbatches and other plastics compounds, within the plastic industry. The company recently 
made a smart shift towards sustainability, changing the paradigm and the bad publicity of plastics, aiming to adapt its 
business to meet current concerns. The investment yields a 3.3x money multiple. The plastic industry is essential to 
our society, representing a market expected to grow at a 4.2% CAGR, reaching a market value of approximately 
$754b by 2027, being partially explained by the increase in demand for bioplastics. Kompuestos is a well-established 
firm, generating € 46.2m in revenue and an EBITDA of € 3.3m, as of 2019. 
I would like to thank my advisor, Professor Inês Lopo Carvalho, for the guidance and support during the elaboration of the Thesis.
I would like to thank my group members for all the determination and proficiency demonstrated throughout these past months.
Finally, a kind word to all my fellow colleagues that I somehow contacted with during the course of the Master’s in Finance.
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o Valued at 9.4x EV/EBITDA at entry and exit, Kompuestos
yields a total return of 3.3x MM over the 6-year investment 
period and a 21.8% IRR
A. Introduction | Executive summary
Kompuestos delivers high returns to institutional investors, yielding a 3.3x MM and a 21.8% IRR
Company overview Market overview
Entry rationale Exit and returns
o The plastic industry is characterized by a fragmented market
where large companies cohabit with smaller ones. The
combined global industry is expected to experience strong
growth over the investment period and is predicted to reach a
market volume of approximately $ 721bn by 2025
o Strongest growth is expected from the bioplastic solutions
market with an expected CAGR from 2019 to 2026 of 16%
o The strong growth is fuelled by several trends in the
underlying end markets such as the rise in demand of
recycled plastic, bioplastics and larger focus on R&D
Sources In €m EBITDA x Uses In €m EBITDA x
Debt 11.5 3.1x EV 34.9 9.4x
Equity 24.4 6.6x Fees 1.0 0.3x
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o Well established company with healthy cash flows
after intensive historical Capital expenditure; room for
margin optimization; leverageable balance sheet
Robust fundamentals1
o +1,200 cross sector worldwide clients, where the 3
biggest clients account for only 20% of sales
Diversified client pool2
o Actionable mega trends, significant growth
projections, increasing demand for strategic products
and shift of the market towards sustainability
Optimistic industry trends3
o Leadership with a good




o Wide range of quality
products to fulfil all
areas of demand,
including sustainable
solutions to surf in high
growth segments
Diversified product range5
Returns 2021E 2022E 2023E 2024E 2025E 2026E
Management MM 2.2x 3.3x 4.5x 5.9x 8.1x 10.7x
Management IRR 124.8% 82.1% 65.5% 55.9% 53.1% 48.4%
Fund MM 1.3x 1.6x 1.9x 2.2x 2.7x 3.3x
Fund IRR 29.5% 25.1% 23.1% 21.9% 22.0% 21.8%
o Kompuestos is a Spanish industrial
company dedicated to the production and
marketing of masterbatches and polymers
to the plastic industry. Their revenue is
divided in plastic derivatives made from
traditional resources and includes a
production unit dedicated to the bioplastic
solutions
o The company is present in +44 countries
has clients from several industries.
Kompuestos is based in Catalonia, Spain
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KPIs (in €m) 2020 2021 2022 2023 2024 2025 2026
Total revenue 47.2 50.1 53.1 56.4 59.9 63.6 67.7
Growth 2.1% 6.0% 6.1% 6.2% 6.2% 6.3% 6.3%
Gross profit 14.3 15.2 16.1 17.2 18.3 19.5 20.8
Gross profit margin 30.2% 30.3% 30.3% 30.4% 30.4% 30.5% 30.5%
Normalized EBITDA 3.7 4.4 4.9 5.6 6.2 7.3 8.5
EBITDA margin 7.9% 8.8% 9.3% 9.8% 10.4% 11.4% 12.5%
EBIT 0.1 1.9 2.4 3.0 3.6 4.6 5.8
EBIT margin 0.2% 3.8% 4.5% 5.3% 6.0% 7.2% 8.4%
4
Sources: Statista, GrandViewResearch, Fortune Business Insights
1. Market overview | Plastics market & masterbatches focus
The market is undergoing a transformational period with solid growth expectations
Plastics market overview & outlook
o Plastics are essential in our society, with +350mT produced
annually used to produce industrial and consumer products
o Plastics have key characteristics such as versatility, moldability
and flexibility, along with the cost advantage and easy
manufacturing nature
o Polymers (plastics) are mainly derived from petrochemicals (e.g.
natural gas, crude oil). Environmental awareness has driven
higher demand for sustainable plastic solutions as innovative
and cleaner alternatives are being developed, turning to
renewable sources (e.g. food waste, corn starch, biomass,
vegetable oil, etc…)
o Global market value of plastics reached $ 560bn in 2019 and is
estimated to grow at a 4.2% CAGR until 2027, supported by the
increase of the infrastructure & construction, food & beverages,
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End life - cycle
Supply chain
Segment overview: Masterbatches
o Masterbatches are plastic additives, fillers and resins that allow manufacturers to add
colour or other enhancing characteristics to their plastic products (e.g. UV light
resistance, flame retardation, anti-microbials)
o It is a cheaper and easier alternative to buying fully compounded materials or compounding














Sources: Statista, GrandViewResearch, Fortune Business Insights, Ellen MacArthur Foundation, Plastics Europe, McKinsey & Company, Association of plastics manufacturers, Markets&Markets
1. Market overview | Masterbatches deep-dive
Commitment to the environment created opportunities for manufacturers, opening new high growth markets
Segment overview: masterbatches
o The masterbatch market is expected to reach $ 16.4bn by
2026, growing at a 5.5% CAGR from 2019-2026, mainly driven
by increased activity in the building & construction sectors
o The masterbatch market is quite fragmented, with the
presence of numerous players with varying sizes
− The larger firms make up 60% of the market, with the
rest distributed among smaller players
o The industry is highly competitive due to the low barriers to
entry, as is it not a capital-intensive business and most of
segments do not require major technology investments. This
results in low bargaining power with both clients and suppliers
o This creates a lot of room for consolidation, with companies
wishing to expand their distribution network, vertically integrate
across the supply chain and diversify their product mix, in order


















Compostable & biodegradable plastics:
o Biodegradable plastics forecasted to increase at a 16.7% CAGR from 2018-2027
o The production capacity of the biodegradables is estimated to grow at an annual 




Global market value in $ 









Circular economy: Commitment to sustainability, low/zero waste initiatives and use
of recycled materials creates high growth opportunities
R&D: Perpetual race for the creation of new value-added products and improvement
of the production processes
Waste management: Improvement in the waste management systems makes it
possible to give a new life to the plastic waste through new sustainable products
Plastics from renewable resources:
o Bioplastics are expected to grow at an annual rate of 16.2% from 2018-2026,
reaching $ 20bn, and increasing its market share in the plastics industry to 40% by
2040
1175 1200 1200 1190 1179 1244 1328
885 912 994 1026 1026 1113
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Biodegradable
Non-biodegradable
Global capacity of bioplastic production (in mT tons)
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2. Company overview | Company profile & supply chain position 
Plastic compounds producer moving towards sustainable plastic production with € 46.2m in revenue
Company profile
o Based in Barcelona, Kompuestos is a producer of masterbatches (colour, black, white and additive) and other plastic
compounds (such as bio resins and recycled polymers), being one of the biggest European producers of mineral fillers (with c.
10% market share in Europe and 5% globally globally) Their products, which have a high natural component, are globally used
as raw materials in many industries to produce all types of plastics
– Employs +70 employees across 2 production plants, generating a revenue of € 46.2m and an EBITDA of € 3.3m in 2019
o Kompuestos is listed in the Spanish Alternative Market (MAB) since 2019; the public offering aimed to raise capital to finance
the expansion of the bio products’ production capacity, following the spike in demand
o The firm’s current strategy consists of focusing on the development of economies of scale in the production of mineral fillers
and the production of bioplastics, for which it already attained the necessary certifications
o The company has strong environmental commitment, focusing on adding value to plastics and on reducing their carbon
footprint through sustainable innovation, developing biodegradable products and advanced plastic recycling technologies
Key figures
2 production plants 
30 lines of production
Present in +44 countries 
+1,200 clients
Diversified product 

















Masterbatches, fillers and additives
o Masterbatches: concentrated mixture of polymers with pigments
and/or additives. Used to colouring plastics or imparting other
properties (e.g., antioxidant, UV stabilizers) to them
o Fillers: materials added to plastic polymers to reduce the cost of the
compound, improve its properties and lower its carbon footprint. Can
be combined with additives to obtain the desired product features
o Additives: improve the performance of plastics, protecting them
against degradation by heat, ultraviolet rays, oxidation or other agents,
or providing specific features depending on the use of the final product
5
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o Kompuestos produces and sells traditional plastic compounds, seeking also to develop
greener and more sustainable alternatives, such as bio-based and biodegradable plastics
and plastic recycling technologies
2. Company overview | Product mix, company strategy & growth drivers




o In 2019, 92% of the firms’
revenue came from the
traditional products, 5%
from the bio solutions
and 3% from the
recycling and marketing
of raw materials
o Kompuestos’ strategy is to bring together the businesses of traditional plastics and of the bio, compostable and recyclable
plastics. The firm aims to move “towards a sustainable future” and to become a leader in the circular economy of plastics
o Organic growth has been Kompuestos’ main source of growth over the years
o Capacity increase and optimization in production lines to meet demand allowed for a fast revenue growth (real
production capacity tripled since 2016)
o R&D is a key element of the firm’s business model, allowing for a yearly introduction of 100 new formulas. The development
and introduction of new products has been a vital growth driver in the last few years (as of 2019, 80% of the firm’s
revenues derived from products released in the last 5 years). Kompuestos was an early identifier of the need to adapt to the
growing environmental concerns, doing so by using its R&D strengths to develop bioplastics and plastic recycling techniques
o As of 2019, the bio line of production was roughly 5,000 mT and is expected to keep growing as, in the coming years,
bioplastics are expected to be a significant growth driver, as they capture new clients and introduce more ecological
solutions to the existing ones
Company strategy and growth drivers
Real capacity increase
40 000 40 000



















o Kompuestos derives its revenue from the sale of the different
products included in the previously mentioned product lines
The company offers to its clients a diversified product portfolio, allocated to 3 different lines:
1. Traditional products: mineral fillers, colour, black, white and additive masterbatches
2. Bio solutions: biodegradable, compostable and some water soluble bio-based resins
3. Recycling & marketing of raw materials: production and sale of recycled plastic polymers
6
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Income Statement (in €m) 2015 2016 2017 2018 2019
Traditional products 27.7 35.3 41.3 42.3
Quantity sold (mT) 33 722 36 545 50 381 56 752
Bio solutions 2.3
Quantity sold (mT) 1 181
Recycling and marketing of 
raw materials
0.9 1.3 0.1 1.6
Quantity sold (mT) 726 1 066 69 1 355
Total revenues 25.1 28.5 36.6 41.4 46.2
Growth 13.9% 28.1% 13.1% 11.7%
Cost of Sales (16.3) (19.1) (26.5) (29.4) (32.3)
% of sales 65.2% 66.8% 72.6% 71.2% 69.8%
Gross profit 8.7 9.5 10.0 11.9 14.0
Gross margin 34.8% 33.2% 27.4% 28.8% 30.2%
Self-constructed assets 0.1 0.5 1.4 1.2 1.6
% of sales 0.3% 1.6% 3.8% 3.0% 3.5%
Personnel expenses (2.6) (2.9) (3.5) (3.3) (3.7)
% of sales 10.4% 10.2% 9.5% 8.1% 8.0%
Other operating expenses (5.2) (5.3) (5.8) (6.1) (8.2)
% of sales 20.9% 18.5% 16.0% 14.7% 17.8%
Normalized EBITDA 1.0 1.8 2.1 3.7 3.7




0.0 0.1 0.0 (0.3) (0.5)
EBITDA 1.0 1.8 2.4 3.8 3.2
EBITDA margin 3.9% 6.4% 6.6% 9.1% 6.9%
D&A 0.0 0.0 0.0 0.0 0.0
Net income (0.5) 0.1 0.1 0.5 0.2


















Total Revenues Gross Margin
Comments
1 Kompuestos has been experiencing a constant growth in revenues, translating into a CAGR of
16.6% between 2015 and 2019
o Increase in production capacity with the creation of a new production line in 2017, enlarging its
real capacity from 40,000mT to 78,000mT. As a result, total quantity sold increased 34.1% in
2018, from 37,611mT 50,450mT
o Creation and implementation of three new bio lines of products in 2018 and consequent results
in 2019 sales-wise, contributing 47.6% to total revenue growth
2 Gross margin has increased c. 2.8% since 2017
o The bio segment implemented in 2019 presents costs that are almost 2.43x higher than the
traditional business (€ 1,270 per mT sold) ones but have a much larger margin compared to
the latter one (€ 723 vs € 222 per mT)
o Traditional business has experienced decreasing costs since 2017, standing at € 520 per
mT in 2019
Income Statement
3. Historical financials | Income statement
Kompuestos has experienced a constant growth in revenues sustained by an increase in its production capacity
Source: Company data
5 A 10.7% increase in 2019 was the result of
strengthening the company's commercial,
research and development and production
structure in order to sustain the growth
targeted for the coming years. The total
number of employees increased from 69 in
2018 to 79 in 2019
4 Incremental R&D activity since 2017 (for bio solutions development) aligned with the new











Change in Net Working Capital (0.3) 0.0 1.9
Net Working Capital 5.1 5.1 3.2
Investment in Op NWC as % of Sales (0.82)% (0.07)% 4.43%
Total Debt 14.9 16.2 12.9
Net debt 14.6 14.0 11.9
Growth% 17% (4)% (15)%
Net debt/EBITDA 6.11x 3.64x 3.60x
Balance Sheet (in €m) 2017 2018 2019
Intangible assets 1.9 2.7 3.6
Property. plant and equipment 17.2 18.1 21.1
Total non-current assets 19.6 21.1 25.2
Inventories 5.4 6.7 7.1
Trade and other receivables 5.5 5.8 4.3
Cash and cash equivalents 0.3 2.2 1.1
Total current assets 11.4 14.9 13.1
Total equity 10.1 12.2 16.9
Total non-current liabilities 6.4 7.8 9.0
Trade and other payables 5.7 7.4 8.2
Total current liabilities 14.5 15.9 12.4
Comments Balance Sheet & Free Cash Flow
3. Historical financials | Balance sheet & Free Cash Flow
Kompuestos exhibits a healthy financial profile
Sources: Company data, GVC Gaesco Beka estimation for Kompuestos
25% decrease in 2019 over the previous year driven by increasing
exports with better collection periods, an over-all improvement in
customer collection management and a selective usage of factoring
financing lines. Decreasing cash conversion cycle towards more







NWC decreased 36.7% following a decrease in accounts receivables and increase in accounts
payable in 2019. Apart from 2019, Kompuestos has generally kept the NWC at stable values
Large cash balance to enable growth through product development and expansion Capex
77%-86% of Capex values were related to expansion which
has been one of Kompuestos’ main growth drivers. Such
increase in the real production capacity of the company
(made to keep up with the current and future growing
demand for plastics) is expected to continue until 2020, and
then stop. Consequently, Capex is expected to decrease
going forward, driven by a null Expansion Capex
4
Core operations do not take into consideration the one-off effects of non-recurring items, finance
income or exchange rate gains/losses. Through this breakdown it is possible to verify the CF from
the company’s core operations. In 2019 the FCF was impacted by a large investment in the
expansion of the production capacity, IPO costs and costs related with the refinancing of debt
6
Growing intangible assets driven by heavy investments in R&D and consequent increasing number
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Free Cash Flow (in €m) 2017 2018 2019
Operating profit 0.4 1.4 1.8
Recurrent Capex 0.0 0.0 (0.9)
Expansion Capex (2.8) (3.1) (4.5)
Intangibles Capex (0.5) (0.9) (0.5)
Working capital needs (0.5) (0.1) 1.8
FCF Core Business (1.7) (0.6) (0.9)
FCF Non Core Business 0.3 0.0 (0.7)






o Growing company, with a sustained growth in revenues
– CAGR of 17% (2016-2019) – a rising gross profit
(13% CAGR) and stable gross margins (c. 30%, in line
with the peers’ average)
o Growing normalized EBITDA (28% CAGR – 2016-
2019) sustained by an overall expansion of the firm
o Net debt to EBITDA ratio has been decreasing driven
by incremental EBITDA and diminishing debt
o Negative CF generation in the last 3 years due to high




Operations in a growing and fragmented market Diversified client base and product range, 
with sustainable solutions offered
Growth strategy and drivers
Meet traditional business demand
o Take advantage of the early
identification of the market shift to
bio plastics, the current constraints
imposed by regulations and the
knowledge acquired through R&D to
deliver higher quantities of bio
solutions, with increased quality and
diversification
o Increasing production of recycled
polymers and bio solutions allows
for a slight decline in COGS as a
percentage of revenues
o EBITDA margin expansion to meet
its peers’ average, mainly through
the optimization of other operating
expenses
o Producing polymers from recycled
plastics creates a new source of
revenue for the firm, while contributing
to reduce the consumption of virgin
polymers in the industry and allowing
Kompuestos to increase the share of











Broad plastics Masterbatches Recycled
plastics
Bioplastics
Markets' CAGR 2018-2026 Potential European leader in fillers and
bio solutions, present in +44 countries
+1,200 long-term clients, with no
evidences of a specific sector dependency:
diversification of clients hedge against
sector specific risks
Diversified product portfolio, offering 
sustainable solutions
Ability to be a main player in bio
solutions due to a superior position to
attack the shifts in the market, high
innovation capability and industry
expertise
o The traditional business expects a
steady growth, with the firm
adapting its production to a future
growing demand
o Traditional products’ clients are
important to the bio solution range
commercialization
Increase bio solutions’ production Increase efficiency
o Highly qualified professionals with relevant industry 
expertise
Well-established company with attractive financials
Kompuestos is a well-established firm, operating in a growing market, with growing sustainability concerns 
Sources: Team analysis, company data




5. Business plan | Revenue model
Solid revenue streams with strong opportunities to grow, notably from the bio segment
Revenue breakdown
Traditional total quant. sold (mT) 33 722 36 545 50 381 56 752 55 200 58 181 61 323 64 634 68 125 71 803 75 681
Traditional sales (in €m) 27.7 35.3 41.3 42.3 43.2 45.6 48.1 50.8 53.6 56.6 59.7
Growth 27.6% 17.0% 2.5% 2.1% 5.5% 5.5% 5.5% 5.5% 5.5% 5.5%
Revenue per mT 0.8 1.0 0.8 0.7 0.8 0.8 0.8 0.8 0.8 0.8 0.8
Bio solutions total quant. sold 
(mT)
1 181 1 206 1 400 1 625 1 887 2 190 2 543 2 952
Bio solutions sales (in €m) 2.3 2.4 2.7 3.2 3.7 4.3 5.0 5.8
Growth 2.1% 16.1% 16.1% 16.1% 16.1% 16.1% 16.1%
Revenue per mT 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Recycled raw materials total 
quant. sold (mT)
726 1 066 69 1 355 1 383 1 501 1 629 1 767 1 917 2 080 2 257
Raw materials sales (in €m) 0.9 1.3 0.1 1.6 1.6 1.8 1.9 2.1 2.3 2.5 2.7
Growth 46.8% -93.5% 1851.3% 2.1% 8.5% 8.5% 8.5% 8.5% 8.5% 8.5%
Revenue per mT 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2
Key Value Drivers
Installed production facility and previously increased real production capacity 
allows a quicker expansion across all business units
Traditional 











Revenue Breakdown (in €m) 2016 2017 2018 2019 2020E 2021E 2022E 2023E 2024E 2025E 2026E
Traditional total quantity sold (mt) 34.4 37.6 50.5 59.3 57.8 61.1 64.6 68.3 72.2 76.4 80.9
Total sales 28.5 36.6 41.4 46.2 47.2 50.1 53.1 56.4 59.9 63.6 67.7
Growth 28.1% 13.1% 11.7% 2.1% 6.0% 6.1% 6.2% 6.2% 6.3% 6.3%
o Sales grew at a 16.6% CAGR from 2015-2019, with Covid-19
disrupting Kompuestos of achieving a double-digit growth in 2020.
2H 2020 sales were computed based on a 2.1x multiplication factor,
easily explained by the fewer restrictive rules and increased
economic activity, as the normal deals of the 1st part of the year were
relegated to the 2nd. Being closely correlated with the food retail
business, a sector registering a +10% growth in 2020, the 2% growth
projected is surely not underestimating the Covid-19 impact
o Traditional sales, the backbone of the company, grew at a 15.2% CAGR
from 2016-2019, and are expected to follow the same pace of the
masterbatches market (5.5%) from 2021 onwards
o Bio solutions are forecasted to follow the market growth of 16.1% from
2021 onwards as the Kompuestos is in a good position to attack the
growing demand, and seize the opportunity given their new bio
production line, increased capacity installed and R&D efforts
o Recycled raw materials experienced some oscillations; however, the
production facilities are ready to mass produce this product, meeting the
market demand and the 8.5% expected market growth
Sources: Team analysis, company data
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EBITDA margin deconstructed forecast
5. Business plan | Operating model
Space for margin optimization and growth
EBITDA breakdown
Income Statement (in €m) 2016 2017 2018 2019 2020E 2021E 2022E 2023E 2024E 2025E 2026E
Total revenue 28.5 36.6 41.4 46.2 47.2 50.1 53.2 56.6 60.2 64.0 68.2
Traditional products COGS 18.5 25.6 29.4 29.7 30.3 32.0 33.8 35.6 37.6 39.7 41.9
% of sales 66.8% 72.6% 71.2% 70.2% 70.2% 70.2% 70.2% 70.2% 70.2% 70.2% 70.2%
Bio solutions COGS 1.5 1.5 1.7 2.0 2.3 2.7 3.1 3.6
% of sales 62.8% 62.8% 62.8% 62.8% 62.8% 62.8% 62.8% 62.8%
Recycled raw materials 
COGS
0.6 0.9 0.1 1.1 1.1 1.2 1.3 1.4 1.6 1.7 1.8
% of sales 66.8% 72.7% 71.2% 68.8% 68.8% 68.8% 68.8% 68.8% 68.8% 68.8% 68.8%
Total cost of sales 19.1 26.5 29.4 32.3 32.9 34.9 37.1 39.4 41.9 44.5 47.4
% of sales 66.8% 72.6% 71.2% 69.8% 69.8% 69.7% 69.7% 69.6% 69.6% 69.5% 69.5%
Gross profit 9.5 10.0 11.9 14.0 14.3 15.2 16.1 17.2 18.3 19.5 20.8
Gross profit margin 33.2% 27.4% 28.8% 30.2% 30.2% 30.3% 30.3% 30.4% 30.4% 30.5% 30.5%
Other operating income 0.5 1.4 1.2 1.6 1.1 1.7 1.8 1.9 2.1 2.2 2.3
% of sales 1.6% 3.8% 3.0% 3.5% 2.4% 3.4% 3.4% 3.4% 3.4% 3.4% 3.4%
Personnel expenses 2.9 3.5 3.3 3.7 3.8 4.1 4.4 4.7 5.0 5.3 5.6
% of sales 10.2% 9.5% 8.1% 8.0% 8.0% 8.2% 8.2% 8.2% 8.2% 8.2% 8.2%
Other operating expenses 5.3 5.8 6.1 8.2 7.9 8.4 8.6 8.9 9.2 9.1 9.0
% of sales 18.5% 16.0% 14.7% 17.8% 16.7% 16.7% 16.2% 15.7% 15.2% 14.2% 13.2%
D&A 1.1 1.7 2.3 1.8 2.5 2.5 2.5 2.6 2.6 2.7 2.7
% of sales 4.0% 4.7% 5.6% 4.0% 5.2% 5.0% 4.8% 4.6% 4.4% 4.2% 4.0%
EBIT 0.7 0.7 1.8 1.9 0.1 1.9 2.4 3.0 3.6 4.6 5.8
EBIT margin 2.4% 2.0% 4.3% 4.1% 0.2% 3.8% 4.5% 5.3% 6.0% 7.2% 8.4%
Normalized EBITDA 1.8 2.1 3.7 3.7 3.7 4.4 4.9 5.6 6.2 7.3 8.5
EBITDA margin 6.2% 5.8% 9.1% 7.9% 7.9% 8.8% 9.3% 9.8% 10.4% 11.4% 12.5%
Normalization adjustments 0.1 0.3 0.4 0.1 (1.2) 0.0 0.0 0.0 0.0 0.0 0.0
EBITDA 1.8 2.4 3.8 3.2 2.6 4.4 4.9 5.6 6.2 7.3 8.5
EBITDA margin 6.4% 6.6% 9.1% 6.9% 5.4% 8.8% 9.3% 9.8% 10.4% 11.4% 12.5%
o The traditional business is the one with the highest COGS as %
sales, with no significant changes in this ratio since 2016
o Regarding bio solutions, the peer average COGS as % of sales was
considered, being at a lower % when compared to the traditional
o In general, the gross profit margin of the recycled raw materials is
higher than the traditional. In 2019, the COGS as % of sales in this
segment were calculated by difference, resulting in a COGS as % of
sales of 68.8%
o Operating income margin was calculated using an average of the
last 3 years (3.4%), except for 2020, where the company was
impacted by Covid-19, registering 2.4% for the 1H 2020. In order to
avoid underestimations of the pandemic this same value was used
for the FY 2020. This item includes self constructed assets and
nonfinancial and other capital gains, the first one (non-cash income),
decline due to the deceleration of R&D, and the second declined due
to the decrease in capital gains
o Personnel expenses were calculated based on the number of
employees and revenue per employee, depreciation was calculated
based on the real production capacity installed and amortization
based on the R&D expenses
Market growth trend and lower
production cost in alternative products
Margins moving towards peer’s average, 






Sources: Team analysis, company data
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5. Business plan | Free cash flow
Kompuestos is expected to continuously generate cash, while EBITDA is expected to grow at a 15% CAGR
Comments
Cumulative cash flows for the firm (€m)
• Very strong EBITDA growth at c. 15% CAGR enabled through 
margin optimization and growth of core operations
1
• D&A dependent on the real capacity installed and investments 
made in intangibles
2
• Recurrent and Intangibles Capex is based on % sales,
growing in line with overall growth of the company. Expansion
Capex is dependent on the real capacity installed, that is
projected to remain constant after the capacity increase made
in 2020. The majority of the historical Capex was attributed to
the Expansion Capex, that is projected to be no longer
required
3
• NWC remains negative during the investment period4
• The FCF from Core Business includes the operating activities
took by the company without the effect of one-off items. From
this it is possible to have an idea of the CF from the normal
activity of the company, with the effect of the Core operating
income and the Core invested capital
5
• Accounts with one-off items such as grants and other non-
recurrent expenses take into account the increase in non-core
invested capital (current and noncurrent investments made by
the company that have nothing to do with the Core operations
of the company)
6
Sources: Team analysis, company data
Free Cash Flow (in €m) 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Core Business FCF
Core Result (NOPLAT) 0.3 1.1 1.4 0.9 1.4 1.8 2.2 2.7 3.5 4.3
Depreciation & Amort. 1.7 2.3 1.8 2.5 2.5 2.5 2.6 2.6 2.7 2.7
Operational Cash flow 2.0 3.4 3.2 3.4 3.9 4.4 4.8 5.3 6.2 7.1
Recurrent Capex 0.0 0.0 (0.9) (0.9) (1.0) (1.0) (1.1) (1.2) (1.3) (1.3)
Expansion Capex (2.8) (3.1) (4.5) (4.4) 0.0 0.0 0.0 0.0 0.0 0.0
Intangibles Capex (0.5) (0.9) (0.5) (0.7) (0.8) (0.8) (0.9) (0.9) (1.0) (1.0)
Working Capital needs (0.5) (0.1) 1.8 (2.0) (0.4) (0.4) (0.4) (0.5) (0.5) (0.6)
FCF Core Business (1.7) (0.6) (0.9) (4.6) 1.8 2.1 2.4 2.8 3.4 4.1
(
FCF Non-Core Business 0.3 0.0 (0.7) (0.9) 0.0 0.0 0.0 0.0 0.0 0.0
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6. Exit and returns | Capital structure
Debt schedule consists of senior loans A and B priced at 2.75% and 2.85% respectively, with a leverage of 3.1x EBITDA
Comments
o Total funds are sourced from an equity contribution of 6.6x
EBITDA (€ 24.4m) and leverage of 3.1x EBITDA (€ 11.5m)
o Total debt is composed by Tranche A with € 9.3m of
amortizable senior debt, and Tranche B with € 2.2m of senior
debt to be fully repaid in 2027. The equity strip comprises a
subordinated loan of € 19.5m and ordinary equity of € 4.9m.
Management team’s sweet equity contribution of € 0.7m is
100% of their combined yearly salary
o Total uses of funds, amounting to € 36.0m, are to be paid
for the EV of € 34.9m and fees of € 1.1m
o The EV is based on an entry multiple of 9.4x EBITDA
Sources and uses of funds
Sources: Team analysis, company data & Santander DCM team advisory





• Type of debt: Senior debt, 
tranches A and B, both secured
• Additional instruments: 
Acquisition Capex facility
• Maximum leverage: 3.1x EBITDA
• Pricing: 2-3% of interest rate
• Maturity: 6-7 years








Sources of funds (in €m) x EBITDA % Interest Uses of funds (in €m) %
Senior debt Normalized EBITDA 2020 3.7
Term Loan A 9.3 2.5x 25.8% 2.75% Multiple 9.4x
Term Loan B 2.2 0.6x 6.2% 2.85%
Total debt 11.5 3.1x 32.0%
Enterprise value 34.9 97
Fixed Return Instrument 19.5 4.3x 44.9%
Ordinary Equity 4.9 1.3x 13.7% Financing fees
Institutional Ords 4.2 DD fee 0.2 0.5
Management Sweet Equity 0.7 Arrangement fee 0.2 0.5
Other fees and expenses 0.7 2
Total equity 24.4 6.6x 68.0% Total fees 1.1 3






Debt Ordinary Shares Term A
Term B Sub-Loan Ords
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6. Exit and returns | Debt repayment, credit statistics, exit returns & value creation 
Exiting in 2026 delivers a 3.3x MM to institutional investors and a 10.7x MM to the management team  
Institutional and management returnsCash-flows for debt service and repayment (in €m) 
Returns (€ m) 2021E 2022E 2023E 2024E 2025E 2026E
Management Exit Proceeds 1.7 2.5 3.4 4.4 6.0 7.9
Management Equity 0.7 0.7 0.7 0.7 0.7 0.7
Management MM 2.2x 3.3x 4.5x 5.9x 8.1x 10.7x
Management IRR 124.8% 82.1% 65.5% 55.9% 53.1% 48.4%
Institutional Investor Exit 
Proceeds
30.7 37.1 44.3 52.3 64.1 77.6
Institutional Investor Equity 23.7 23.7 23.7 23.7 23.7 23.7
Institutional Investor MM 1.3x 1.6x 1.9x 2.2x 2.7x 3.3x
Institutional Investor IRR 29.5% 25.1% 23.1% 21.9% 22.0% 21.8%
Credit statistics
Exit waterfall 2026 (in €m)
2021E 2022E 2023E 2024E 2025E 2026E
Cash Cover 1.5x 1.8x 1.5x 1.5x 1.6x 2.0x
Net Debt / EBITDA 2.0x 1.4x 0.8x 0.3x (0.2)x (0.7)x
Interest Cover 13.4x 16.7x 21.2x 28.9x 47.7x 116.2x
Sources: Team analysis, company data
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7. Exit strategy | Valuable strategic sale
The most attractive strategy is to pursue a strategic sale as potential synergies translate in a higher exit multiple
Strategic sale IPO & other alternativesSecondary sale
o Sale to a direct competitor or a company along
the supply chain, with the aim of expanding its
product mix or geographical reach, or looking to
vertically integrate its operations
1. Direct competitor looking to expand to the
European market, improve logistics or obtain
access to a large and diversified client base
2. Plastics good manufacturer aiming to
increase control over processes or improve
efficiencies by acquiring a supplier
o Synergies created support a higher exit
multiple following the potential for value creation
incentivizing buyers to pay a higher premium
o Given the highly fragmented nature of the
market, in 5-7 years, a wave of mergers and
acquisitions is highly probable
o Sale to a private equity firm as the market is
expected to remain attractive with potential to
implement alternative value added strategies
o Financial sponsors are likely to continue to have
large amounts of capital to invest following
increased demand from investors
o This exit usually allows for an easier and faster
process, with more flexible agreements, but the
price may not be as favourable when
compared to the strategic sale given that
synergies are less likely
o An ideal buyer would include a PE firm operating
company involved in the plastics industry looking
to pursue “buy-and-build” strategies, or in similar
geographies allowing for potential synergies to be
created
o IPO: A public offering on the Madrid Stock
Exchange has the potential to expose the firm to
a larger pool of investors, yet it is subject to a
high regulatory framework and highly
dependent on market conditions (e.g. investor
sentiment). Additionally, the transactions costs
involved, time required and restrictions imposed
by standard lock-up agreements reduce this
option’s attractiveness, specially considering the
size of Kompuestos
• Direct Listing: Alternative to traditional IPO when
there is no need to raise capital, being, given the
lack of underwriters, a cheaper option.
Additionally, there are no lock-up agreements,
yet it is still very dependant on market
conditions and investors’ perceptions
• Sale to the management/ founding family:
Management or founding family may be interested
in taking control of the company, however, this is
highly unlikely given the size of the transaction
• Dual-track process: Filling the IPO prospectus
while searching for a strategic buyer allows to
gain perception of both capital markets’ sentiment
and strategic buyers’ interest. This may increase
returns, yet it is very costly




Private Equity Challenge – Individual Presentation
6. Exit and returns
7. Exit strategy
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6. Exit and returns | Capital structure
Kompuestos’ internal factors and optimistic market prospects allow for a BB rating
Capital structure – key takeaways Kompuestos’ leverage determinants
Kompuestos’ projected debt conditions
Rational behind rating
− No revenue exposure to highly cyclical markets
− No regional concentration
− Expectations of moderate revenue growth and
margin optimization
− Stable to modest growth in traditional business
and high growth in bio solutions segment
o Operating Model: the operating model is a key input to the LBO model because of all the previously
explained growth forecasts and assumptions that greatly affect the model
o Enterprise Value: The multiple for 2020, considering both relative and intrinsic valuation, was that of 9.4x.
Despite the plastics market is expected to grow, the exit multiple will be kept equal to the entry one
o Capital structure: Given the current company status (although there is no dependency from a specific
sector, the majority of sales comes from packaging in the food industry), starting point to estimate debt
instruments and consequent pricing based on plastics debt market
− Max. leverage of c. 3.1x EBITDA, since there are no significant Capex requirements in the future
− Debt rating, average: BB (following peer’s average credit rating)
− Debt should be amortized and issued in Spain, priced at 2-3%
− Senior debt is advisable, with max. 2 tranches, and a maturity of 6 to 7 years
− Payments regarding debt are constantly made up of principal repayments and interest expenses
− The Fixed Return Instrument (FRI) will be paid exclusively in PIK interest
− Capex facility of 50% with a drawdown period of four years and a repayment period of another four
Cash flows
Plastic market is expected to grow, sales 
are contractual and predicted
No regional concentration and sector
dependency
Historically volatile FCF due to 
investments made in Capex
No significant expected NWC and Capex 
outflows 
Assets




Diversified end-markets reduce cyclically 
exposure
High growth in end market segments, 
both traditional and sustainable solutions 
market are expected to grow






• Type of debt: Senior debt, tranches A and B, both 
secured
• Additional instruments: Acquisition Capex facility
• Maximum leverage: 3.1x EBITDA
• Pricing: 2-3% of interest rate
• Maturity: 6-7 years
Changes in capital structure (in €m)






Debt Ordinary Shares Term A Term B Sub-Loan Ords
6
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6. Exit and returns | Returns
Returns in the investment case are robust and sensitive to exit year
Investment case Base case Bank case
Source: Team analysis, company data
MM assuming 9.4x entry multiple MM assuming 9.4x entry multiple MM assuming 9.4x entry multiple
Exit Year









7.4x 1.5x 1.8x 2.3x 2.5x 2.7x
8.4x 1.7x 2.1x 2.5x 2.8x 3.0x
9.4x 1.9x 2.3x 2.8x 3.0x 3.3x
10.4x 2.1x 2.6x 3.1x 3.3x 3.6x
11.4x 2.3x 2.8x 3.4x 3.6x 3.9x
Exit Year









7.4x 1.8x 2.2x 2.7x 2.9x 3.2x
8.4x 2.0x 2.4x 3.0x 3.2x 3.5x
9.4x 2.2x 2.7x 3.3x 3.6x 3.9x
10.4x 2.4x 3.0x 3.6x 3.9x 4.2x
11.4x 2.7x 3.2x 3.9x 4.2x 4.5x
IRR assuming 9.4x entry multiple
MM assuming 12.5% exit EBITDA margin
Exit Year









7.4x 15.2% 16.9% 17.7% 16.6% 15.7%
8.4x 18.7% 19.6% 19.9% 18.3% 17.1%
9.4x 21.9% 22.0% 21.8% 19.9% 18.5%
10.4x 24.9% 24.3% 23.7% 21.4% 19.7%
11.4x 27.7% 26.4% 25.4% 22.8% 20.8%
Exit Year









10.5% 2.2x 2.6x 2.9x 3.2x 3.5x
11.5% 2.3x 2.6x 2.9x 3.2x 3.4x
12.5% 2.6x 3.0x 3.3x 3.6x 4.0x
13.5% 2.7x 3.0x 3.3x 3.6x 3.9x
14.5% 2.9x 3.2x 3.5x 3.8x 4.1x
Exit Year









7.4x 1.6x 2.0x 2.4x 2.7x 2.9x
8.4x 1.8x 2.2x 2.7x 3.0x 3.2x
9.4x 2.0x 2.5x 3.0x 3.3x 3.5x
10.4x 2.2x 2.7x 3.3x 3.6x 3.8x
11.4x 2.4x 3.0x 3.6x 3.9x 4.1x
IRR assuming 9.4x entry multiple
MM assuming 11.5% exit EBITDA margin
Exit Year









7.4x 12.3% 14.6% 15.9% 15.0% 14.2%
8.4x 15.9% 17.4% 18.1% 16.7% 15.7%
9.4x 19.1% 19.9% 20.1% 18.4% 17.1%
10.4x 22.2% 22.2% 22.0% 19.9% 18.3%
11.4x 25.0% 24.3% 23.7% 21.3% 19.5%
Exit Year









10.5% 2.1x 2.4x 2.7x 3.0x 3.2x
11.5% 2.2x 2.4x 2.7x 3.0x 3.2x
12.5% 2.5x 2.8x 3.2x 3.4x 3.7x
13.5% 2.6x 2.8x 3.1x 3.4x 3.6x
14.5% 2.8x 3.0x 3.4x 3.6x 3.9x
IRR assuming 9.4x entry multiple
MM assuming 10.5% exit EBITDA margin
Exit Year









7.4x 10.4% 13.0% 14.5% 13.7% 13.1%
8.4x 14.0% 15.8% 16.8% 15.6% 14.6%
9.4x 17.3% 18.4% 18.8% 17.2% 16.0%
10.4x 20.3% 20.7% 20.7% 18.7% 17.3%
11.4x 23.1% 22.9% 22.5% 20.2% 18.5%
Exit Year









10.5% 2.0x 2.3x 2.6x 2.8x 3.0x
11.5% 2.1x 2.3x 2.6x 2.8x 3.0x
12.5% 2.4x 2.7x 3.0x 3.2x 3.5x
13.5% 2.5x 2.7x 3.0x 3.2x 3.5x
14.5% 2.7x 2.9x 3.2x 3.5x 3.7x
7
20
A base case business model delivers a return of 3.00x for a 20.1% IRR
6. Scenario manager | LBO output – Base case
Summary financial data
Uses of funds (in €m)
Entry EBITDA 2020 (normalized) 3.7
Entry EBITDA multiple 9.4x






2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue 46.2 47.2 50.0 53.0 56.2 59.6 63.3 67.2 69.8 72.5
Revenue growth 11.7% 2.1% 5.9% 6.0% 6.0% 6.1% 6.2% 6.2% 3.9% 3.9%
EBITDA 3.2 2.6 4.1 4.7 5.2 5.9 6.9 8.1 8.4 8.7
EBITDA margin 5.4% 8.3% 8.3% 8.8% 9.3% 9.9% 10.9% 12.0% 12.0% 12.0%
EBIT 1.4 0.1 1.6 2.1 2.7 3.3 4.3 5.3 5.5 5.8
EBIT margin 2.9% 0.2% 3.3% 4.0% 4.8% 5.5% 6.7% 7.9% 7.9% 7.9%
Maintenance Capex % sales 2.5% 2.5% 2.5% 2.5% 2.5% 2.5% 2.5% 2.5%
Expansion Capex % sales 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0%
Source: Team analysis, company data
Sources of funds (in €m) x EBITDA % Interest Uses of funds (in €m) %
Senior debt Normalized EBITDA 2020 3.7
Term Loan A 9.3 2.5 25.8% 2.75% Multiple 9.4x
Term Loan B 2.2 0.6 6.2% 2.85%
Total debt 11.9 3.1x 32.0%
Enterprise value 34.9 97%
Fixed Return Instrument 19.5 4.3 44.9%
Ordinary Equity 4.9 1.3 13.7% Financing fees
Institutional Ords 4.2 DD fee 0.2 0.5%
Management Sweet Equity 0.7 Arrangement fee 0.2 0.5%
Other fees and expenses 0.7 2%
Total equity 24.4 6.6x 68.0% Total fees 1.1 3%
Total sources 36.0 9.7 100% Total uses 36.0 100%
2021E 2022E 2023E 2024E 2025E 2026E
Cash Cover 1.3x 1.5x 1.3x 1.2x 1.2x 1.6x
Net Debt / EBITDA 2.3x 1.7x 1.2x 0.7x 0.2x (0.3)x
Interest Cover 12.4x 15.2x 18.8x 24.6x 38.0x 75.5x
18
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With a very conservative business plan returns are of 2.81x for a 18.8% IRR
6. Scenario manager | LBO output – Bank case
Summary financial data
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue 46.2 47.2 49.9 52.7 55.8 59.0 62.5 66.3 68.6 71.1
Revenue growth 11.7% 2.1% 5.7% 5.7% 5.8% 5.8% 5.9% 6.0% 3.6% 3.6%
EBITDA 3.2 2.6 4.0 4.5 5.1 5.7 6.7 7.8 8.1 8.3
EBITDA margin 5.4% 8.3% 8.0% 8.5% 9.1% 9.6% 10.7% 11.7% 11.7% 11.7%
EBIT 1.4 0.1 1.5 2.0 2.5 3.1 4.0 5.1 5.3 5.5
EBIT margin 2.9% 0.2% 3.0% 3.8% 4.5% 5.2% 6.5% 7.7% 7.7% 7.7%
Maintenance Capex % sales 2.5% 2.5% 2.5% 2.5% 2.5% 2.5% 2.5% 2.5%
Expansion Capex % sales 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0%
Source: Team analysis, company data
Sources of funds (in €m) x EBITDA % Interest Uses of funds (in €m) %
Senior debt Normalized EBITDA 2020 3.7
Term Loan A 9.3 2.5 25.8% 2.75% Multiple 9.4x
Term Loan B 2.2 0.6 6.2% 2.85%
Total debt 11.9 3.1x 32.0%
Enterprise value 34.9 97%
Fixed Return Instrument 19.5 4.3 44.9%
Ordinary Equity 4.9 1.3 13.7% Financing fees
Institutional Ords 4.2 DD fee 0.2 0.5%
Management Sweet Equity 0.7 Arrangement fee 0.2 0.5%
Other fees and expenses 0.7 2%
Total equity 24.4 6.6x 68.0% Total fees 1.1 3%
Total sources 36.0 9.7 100% Total uses 36.0 100%
Uses of funds (in €m)
Entry EBITDA 2020 (normalized) 3.7
Entry EBITDA multiple 9.4x






2021E 2022E 2023E 2024E 2025E 2026E
Cash Cover 1.1x 1.3x 1.1x 1.0x 1.0x 1.3x
Net Debt / EBITDA 2.4x 1.9x 1.4x 1.0x 0.5x 0.0x
Interest Cover 11.8x 14.2x 17.2x 21.9x 32.5x 58.1x
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22
6. Exit and returns | Management incentives
Management incentives include a 15% stake of the ordinary equity
Required fixed return instrument
o The required fixed return rate (required return by the fund before the
management receives any proceeds) was set at 9%
o This value is in line with the calculated WACC (9.5%) and is generous
to the management, in the sense that they should be able to collect
proceeds easier, as the required return by the fund could have been set to
a higher value
o On one hand, a higher fixed return rate would incentivize the
management team to work harder towards achieving better results, in
order to be able to benefit from the remaining proceeds. On the other
hand, a lower fixed return rate allows the management team to receive
more proceeds, which are highly dependent on their performance
o A required fixed return rate of 9% was found to be fair for both the
fund and the management team, allowing for a suitable compensation of
the risk that the fund is being exposed to (as the calculated WACC is
9.5%) and for the management to receive higher proceeds from their
investment
o The table below illustrates the management proceeds receives at the exit
(2026) and the returns obtained if the fixed return rate was higher
Name Responsibility Annual salary 
Ignacio Tuesta CEO & Chairman € 130,000
David Pontones GM & Director € 80,000
Núria Matellán CFO € 80,000
Carlos Cordomí Director € 75,000
Luis  Antas Director € 75,000
Sandra Burgues Director € 75,000
Adria Burgues Director € 75,000
Santiago Roca Director € 75,000
Inigo Martinez Director € 75,000
Total € 740,000
Sweet equity 
o Kompuestos’ acquisition must take into account the management team and those who currently have an important
role in running the business, in order to align interests and goals between the fund and the management team
o Offering a share of the obtained returns is a good way to incentivize the team to work towards meeting the growth
that is expected, since if such happens, the management team will also benefit (otherwise, they also loose money). It
is also a way to incentivize the largest shareholder, who is also CEO & Chairman to sell his stake.
o The management team will be able to take part of the transaction, investing 100% of its annual salary (€ 740,000m)
and benefiting from a 15% stake of the ordinary equity
o This translates into a return of 10.7x at the exit year (€ 7.9m of proceeds)
o The envy ratio of 5.8 shows that the deal is highly favorable to management
o The annual salaries exhibited in the table below were estimated taking into account the position of each member and
the average salaries in Spain for each position
Annual salary estimation
9 % 12 %
Management proceeds € 7.9m € 7.0m
Management returns 10.7x 9.6x
Source: Team analysis, company data
0
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7. Exit strategy | Potential buyer overview (1/2)












− Provides specialised 
polymer materials, services, 
and solutions worldwide
− Offers specialty polymer 
formulations, services, and 
solutions for designers
6
− High overlap of end markets 
making Kompuestos an attractive 
target to increase market position
− Strong financial profile and a solid 
acquisition history, specially in 
Spain, with the acquisition of IQAP
Listed 30.9 4.9
− Operates as a chemical 
company worldwide, part of 
the advanced Polymer 
Solutions market
− Produces plastic solutions, 




− Strong financial position and 
acquisition history, acquiring A. 
Schulman, a European player in the 
masterbatches industry, in 2018
− On the other hand, it is a very large 
and diversified player with focus on 
other segments
Listed 59.3 7.1
− Multinational chemical 
company
− Offers advanced materials 




− Very strong financial position and 
acquisition history
− On the other hand, is a very large 
and diversified player with focus on 
other segments
Private 0.2 -
− Manufactures and supplies 
masterbatches, high 
performance plastics and 
polymer additives
1
− Player with a smaller dimension
− Recently bought Controlled 
Polymers, European player in the 
masterbatch industry, allowing the 
company to grow in the European 
masterbatch market
Source: Mergermarket, company data
1
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PE firms are showing an increasing interest in the plastic sector
Potential secondary sale buyer





− Private equity firm investing in 
manufacturing companies with 
revenues between USD 5m to 
USD 500m
19
− Recently acquired a UK-based 
company engaged in producing 
recycled plastics compounds
− Kompuestos’ valuation is within the 
boundaries of the average ticket of 
AIAC
Private 114
− Private equity firm focused on 
buyouts and growth capital 
transactions across Europe, 
Asia & North America
+50
− Deep interest in the plastic market, 
recently acquired an US-based 
manufacturer of resin chemistries for 
composites and cast polymer 
applications
− Strong experience in Iberia
− A potential downside may be the 
dimension of the Kompuestos that may 
fall too short for its average ticket
Private 34
− Private equity firm focused on 
small and mid-sized 
companies pursuing a value 
creation strategy
11
− Strong expertise in the Chemical sector
− Closed its 3rd European Middle Market 
fund in November 2020 (€ 1.1bn), with 
a focus on Western Europe
Source: Mergermarket, company data
2
7. Exit strategy | Potential buyer overview (2/2)
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7. Exit strategy | Key Due Diligence areas
Validation of commercial, financial and environmental aspects is crucial to proceed with the transaction
Key Aspects Main Risks Relevance
Commercial
o Further investigate the European market for plastics, particularly for the
bioplastics and the recycled polymers ones
o Assess the ability to differentiate itself on the market and Kompuestos’
pricing strategy of products and compare it with competitors
o Determine the company’s current market share and realistic competitors
o Evaluate real impact from COVID-19 and consequences
▼ Business’ high dependency on raw materials and corresponding availability
and price
▼ Customers: inability to satisfy clients and to sign long-term contracts
▼ Mandatory certification for new products developed takes time and is not
certain
Financial
o Analyse non-recurrent income (expenses) figure and validate its values 
when computing the normalized EBITDA
o Understand the major changes in NWC within the 2019-2020 period
o Analyse thoroughly the balance sheet, taking into consideration the recurrent
WC requirements and net debt position
o Validate projections concerning EBITDA, NWC and Capex, and the
underlying assumptions
o Analyse the “self-constructed assets” figure
▼ Lower profit margin in the bioplastic and recycled polymers businesses than
expected
▼ Extremely high fixed costs
▼ Inefficient management of working capital
▼ Overestimation of self-constructed assets
Operational
o Investigate if the R&D is being efficiently and timely applicated on the
development of new/increased quality products
o Explore the efficiency of production and usage of assets (mainly machinery)
o Conduct an analysis to identify excessive supplier dependences and
evaluate ways of redesigning contracts to derive benefits for the firm
▼ Inability to properly apply R&D findings, especially when compared to peers
▼ Inefficient usage of production machinery
▼ Excessive supplier dependences and/or extremely low bargaining power
Legal
o Verify company’s licenses, product certifications and registered patents
o Review the contracts that provide assurance for the firm, its assets and
employees
o Confirm Kompuestos’ low exposure to single-use plastics regulation
▼ Future limiting regulations concerning plastics may undermine the traditional
business which is still the main source of revenue
▼ R&D-oriented industry may lead to litigation processes involving IP rights
Management Team
o Conduct a deep analysis of the management team, focused on their
expertise, core competences and suitability
o Assess the areas of strengths of the team
Environmental
o Assess the compliance with current environmental policies and investigate
potential future environmental exigencies
▼ Lack of compliance with tax and environmental legislation requirements





Individual reflection | Key takeaways
Challenging work project in a particular environment to enhance success in a future work experience
o The Private Equity Challenge was a major milestone in my life, not only because it meant that the Masters in Finance provided by Nova SBE had come to an end, but
also because I was able, alongside the other group members, to get in touch with a subject of interest, such as Private Equity. Being able to perform a thesis in
something that actually matters to me was an amazing and defying opportunity
o The first substantial adversity was the company selection, we took some time to successfully surpass this hazard, understanding that this step was vital in order to
prosper in the next phases. A PE target has to have peculiar characteristics and the work performed by the group, which included talking with CEO’s, upset senior
management staff of important companies, etc., until we get the final decision motivated me to overcome the rest of the project
o Secondly, understanding the importance of the group was crucial if in the beginning I was reluctant in working in group, since it is not that common to ear about thesis
in groups, after the first hurdle, it became clear to me the necessity of other group members, not only because of the quality of the work demonstrated by them but
also to motivate me when things get tough
o Finally, all the deadlines established during the elaboration period were essential in order to better organize and divide the required work. All of them were
accomplished triumphantly, also because of the help of the serious and smart guiders’ advice
Personal contribution
Private Equity and the plastic industry
Covid-19 impact
o Probably this is the first time that the PE Challenge is developed under these moulds. We are living in strange times and the capacity to innovate and to show
resilience was surely tested. Covid-19 not only affected interactions among the group members but also raised dilemmas related to the project itself. In addition to the
impossibility of human physical interaction within the group, we had to deal with situations where unpredictable forecasts had to be made, devastating consequences
had to be quantified and risks had to be better accessed. For all of this, the group showed a great capacity to eclipse these issues and perform a best in class project
o PE investments in EMEA grew 25% YoY, from €21.4b in Q3 2019 to a total of €26.7b, in Q3 2020. However, the number of completed deals declined 8% YoY, from
1,303 in Q3 2019 to 1,202 in Q3 2020. The growth in aggregate deal value was partly aided by deals involving German and Southern European targets, meaning that
despite Covid-19, there is a clear evidence that the PE sector was not aggressively affected by it. PE firms must be able to navigate the developments across all
sectors, being required investments in companies that are the best in class within each industry, capable of moving towards sustainability and aligning it with a
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